vs
Arcus Biosciences, Inc.（RCUS）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
RIVERVIEW BANCORP INC的季度营收约是Arcus Biosciences, Inc.的1.3倍（$14.0M vs $11.0M），RIVERVIEW BANCORP INC净利率更高（9.8% vs -963.6%，领先973.4%），RIVERVIEW BANCORP INC同比增速更快（10.4% vs -52.2%），RIVERVIEW BANCORP INC自由现金流更多（$-736.0K vs $-121.0M），过去两年RIVERVIEW BANCORP INC的营收复合增速更高（24.6% vs 4.9%）
Arcus Biosciences是一家处于临床阶段的美国基因编辑上市企业，总部位于北卡罗来纳州达勒姆，成立于2006年。公司依托其专有的“ARCUS”基因组编辑平台，专注于开发体内及体外基因编辑疗法，为相关疾病治疗提供创新解决方案。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
RCUS vs RVSB — 直观对比
营收规模更大
RVSB
是对方的1.3倍
$11.0M
营收增速更快
RVSB
高出62.5%
-52.2%
净利率更高
RVSB
高出973.4%
-963.6%
自由现金流更多
RVSB
多$120.3M
$-121.0M
两年增速更快
RVSB
近两年复合增速
4.9%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $11.0M | $14.0M |
| 净利润 | $-106.0M | $1.4M |
| 毛利率 | — | — |
| 营业利润率 | -1036.4% | 12.4% |
| 净利率 | -963.6% | 9.8% |
| 营收同比 | -52.2% | 10.4% |
| 净利润同比 | -12.8% | 11.8% |
| 每股收益（稀释后） | $-0.88 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RCUSRVSB
| Q4 25 | $11.0M | $14.0M | ||
| Q3 25 | $6.0M | $13.6M | ||
| Q2 25 | $8.0M | $13.3M | ||
| Q1 25 | $8.0M | $12.9M | ||
| Q4 24 | $23.0M | $12.7M | ||
| Q3 24 | $7.0M | $12.8M | ||
| Q2 24 | $11.0M | $12.2M | ||
| Q1 24 | $10.0M | $9.0M |
净利润RCUSRVSB
| Q4 25 | $-106.0M | $1.4M | ||
| Q3 25 | $-135.0M | $1.1M | ||
| Q2 25 | $0 | $1.2M | ||
| Q1 25 | $-112.0M | $1.1M | ||
| Q4 24 | $-94.0M | $1.2M | ||
| Q3 24 | $-92.0M | $1.6M | ||
| Q2 24 | $-93.0M | $966.0K | ||
| Q1 24 | $-4.0M | $-3.0M |
营业利润率RCUSRVSB
| Q4 25 | -1036.4% | 12.4% | ||
| Q3 25 | -2366.7% | 10.2% | ||
| Q2 25 | -100.0% | 11.7% | ||
| Q1 25 | -1525.0% | 11.3% | ||
| Q4 24 | -447.8% | 12.4% | ||
| Q3 24 | -1500.0% | 15.5% | ||
| Q2 24 | -963.6% | 10.0% | ||
| Q1 24 | -160.0% | -47.5% |
净利率RCUSRVSB
| Q4 25 | -963.6% | 9.8% | ||
| Q3 25 | -2250.0% | 8.1% | ||
| Q2 25 | — | 9.2% | ||
| Q1 25 | -1400.0% | 8.9% | ||
| Q4 24 | -408.7% | 9.7% | ||
| Q3 24 | -1314.3% | 12.2% | ||
| Q2 24 | -845.5% | 7.9% | ||
| Q1 24 | -40.0% | -34.7% |
每股收益（稀释后）RCUSRVSB
| Q4 25 | $-0.88 | $0.07 | ||
| Q3 25 | $-1.27 | $0.05 | ||
| Q2 25 | $0.00 | $0.06 | ||
| Q1 25 | $-1.14 | $0.05 | ||
| Q4 24 | $-1.07 | $0.06 | ||
| Q3 24 | $-1.00 | $0.07 | ||
| Q2 24 | $-1.02 | $0.05 | ||
| Q1 24 | $-0.05 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $222.0M | $28.6M |
| 总债务越低越好 | $99.0M | — |
| 股东权益账面价值 | $631.0M | $164.2M |
| 总资产 | $1.1B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.16× | — |
8季度趋势，按日历期对齐
现金及短期投资RCUSRVSB
| Q4 25 | $222.0M | $28.6M | ||
| Q3 25 | $238.0M | $32.8M | ||
| Q2 25 | $248.0M | $34.2M | ||
| Q1 25 | $192.0M | $29.4M | ||
| Q4 24 | $150.0M | $25.3M | ||
| Q3 24 | $201.0M | $31.0M | ||
| Q2 24 | $156.0M | $27.8M | ||
| Q1 24 | $185.0M | $23.6M |
总债务RCUSRVSB
| Q4 25 | $99.0M | — | ||
| Q3 25 | $98.0M | — | ||
| Q2 25 | $97.0M | — | ||
| Q1 25 | $48.0M | — | ||
| Q4 24 | $48.0M | — | ||
| Q3 24 | $47.0M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益RCUSRVSB
| Q4 25 | $631.0M | $164.2M | ||
| Q3 25 | $436.0M | $163.5M | ||
| Q2 25 | $549.0M | $162.0M | ||
| Q1 25 | $531.0M | $160.0M | ||
| Q4 24 | $485.0M | $158.3M | ||
| Q3 24 | $565.0M | $160.8M | ||
| Q2 24 | $635.0M | $155.9M | ||
| Q1 24 | $707.0M | $155.6M |
总资产RCUSRVSB
| Q4 25 | $1.1B | $1.5B | ||
| Q3 25 | $974.0M | $1.5B | ||
| Q2 25 | $1.1B | $1.5B | ||
| Q1 25 | $1.2B | $1.5B | ||
| Q4 24 | $1.1B | $1.5B | ||
| Q3 24 | $1.3B | $1.5B | ||
| Q2 24 | $1.2B | $1.5B | ||
| Q1 24 | $1.3B | $1.5B |
负债/权益比RCUSRVSB
| Q4 25 | 0.16× | — | ||
| Q3 25 | 0.22× | — | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | 0.09× | — | ||
| Q4 24 | 0.10× | — | ||
| Q3 24 | 0.08× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-120.0M | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | $-121.0M | $-736.0K |
| 自由现金流率自由现金流/营收 | -1100.0% | -5.2% |
| 资本支出强度资本支出/营收 | 9.1% | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | — | $20.4M |
8季度趋势，按日历期对齐
经营现金流RCUSRVSB
| Q4 25 | $-120.0M | $-506.0K | ||
| Q3 25 | $-97.0M | $16.8M | ||
| Q2 25 | $-133.0M | $-697.0K | ||
| Q1 25 | $-132.0M | $8.3M | ||
| Q4 24 | $-100.0M | $2.2M | ||
| Q3 24 | $26.0M | $764.0K | ||
| Q2 24 | $-94.0M | $5.4M | ||
| Q1 24 | $-2.0M | $12.8M |
自由现金流RCUSRVSB
| Q4 25 | $-121.0M | $-736.0K | ||
| Q3 25 | — | $16.4M | ||
| Q2 25 | — | $-773.0K | ||
| Q1 25 | $-133.0M | $5.6M | ||
| Q4 24 | $-101.0M | $1.9M | ||
| Q3 24 | $25.0M | $-1.4M | ||
| Q2 24 | — | $5.3M | ||
| Q1 24 | $-6.0M | $7.1M |
自由现金流率RCUSRVSB
| Q4 25 | -1100.0% | -5.2% | ||
| Q3 25 | — | 120.1% | ||
| Q2 25 | — | -5.8% | ||
| Q1 25 | -1662.5% | 43.1% | ||
| Q4 24 | -439.1% | 15.0% | ||
| Q3 24 | 357.1% | -11.3% | ||
| Q2 24 | — | 43.7% | ||
| Q1 24 | -60.0% | 79.0% |
资本支出强度RCUSRVSB
| Q4 25 | 9.1% | 1.6% | ||
| Q3 25 | 0.0% | 2.9% | ||
| Q2 25 | 0.0% | 0.6% | ||
| Q1 25 | 12.5% | 21.0% | ||
| Q4 24 | 4.3% | 2.4% | ||
| Q3 24 | 14.3% | 17.3% | ||
| Q2 24 | 0.0% | 0.9% | ||
| Q1 24 | 40.0% | 62.0% |
现金转化率RCUSRVSB
| Q4 25 | — | -0.37× | ||
| Q3 25 | — | 15.25× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | — | 7.20× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | — | 5.63× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RCUS
| Other | $5.0M | 45% |
| Other Collaboration Revenue | $4.0M | 36% |
| Access Rights And Option Continuation Periods | $2.0M | 18% |
RVSB
暂无分部数据
